NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 85 filers reported holding NGM BIOPHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $10,605,000 | -2.9% | 364,800 | +1.2% | 0.23% | -0.4% |
| Q4 2020 | $10,921,000 | +90.4% | 360,500 | +0.0% | 0.23% | +58.9% |
| Q3 2020 | $5,735,000 | -18.7% | 360,454 | +0.9% | 0.15% | -24.7% |
| Q2 2020 | $7,055,000 | +63.0% | 357,409 | +1.8% | 0.19% | +8.4% |
| Q1 2020 | $4,329,000 | -33.3% | 351,100 | 0.0% | 0.18% | -12.7% |
| Q4 2019 | $6,492,000 | +33.5% | 351,100 | 0.0% | 0.20% | +5.7% |
| Q3 2019 | $4,863,000 | -5.4% | 351,100 | 0.0% | 0.19% | +4.3% |
| Q2 2019 | $5,140,000 | – | 351,100 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,766,666 | $59,928,000 | 49.90% |
| Greenspring Associates, LLC | 1,573,357 | $25,032,000 | 38.95% |
| Svennilson Peter | 18,017,932 | $286,665,000 | 23.39% |
| Aquilo Capital Management, LLC | 1,018,334 | $16,202,000 | 1.72% |
| Jasper Ridge Partners, L.P. | 308,750 | $4,912,000 | 0.28% |
| Samsara BioCapital, LLC | 36,451 | $580,000 | 0.16% |
| Rock Springs Capital Management LP | 360,454 | $5,735,000 | 0.15% |
| Point72 Asset Management, L.P. | 1,611,850 | $25,645,000 | 0.13% |
| Virtus ETF Advisers LLC | 14,880 | $237,000 | 0.12% |
| WELD CAPITAL MANAGEMENT LLC | 15,238 | $242,000 | 0.10% |